If it’s true, this would be good news.  Read this excerpt from a L.A. Times article we found last night:

Clinical cancer trials may become more enticing to patients
By Shari Roan, Los Angeles Times – March 23, 2011

…As the number of clinical trials involving molecular medicine grows, it may be easier to persuade people to participate in the research, said Dr. Richard L. Schilsky, a cancer expert at the University of Chicago Medical Center and author of the commentary. Because of strides in molecular medicine, studies will be based on some knowledge of which people are most likely to benefit. Even early-phase trials are expected to yield some information on how well the therapy might work. Moreover, many molecular therapies don’t carry the harsh side effects of traditional cancer therapies, such as chemotherapy.

Overall, people will be more willing to participate in trials when they believe they may benefit or, at least, won’t be harmed…

You can find the article by clicking HERE.

It isn’t very long.  Check-it out…

Feel good and keep smiling!  Pat & Pattie

Leave a Reply